NCT04256785View on ClinicalTrials.gov

Probiotic VSL#3 for the Treatment of Gastrointestinal Symptoms Associated to Fibromyalgia

NACompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

May 11, 2018

Primary Completion Date

May 31, 2020

Study Completion Date

May 31, 2020

Conditions
FibromyalgiaGastrointestinal Disease
Interventions
DIETARY_SUPPLEMENT

VSL#3

sachets containing probiotic

DIETARY_SUPPLEMENT

Placebo

sachets containing placebo

Trial Locations (1)

18012

"Instituto de Neurociencias Federico Oloriz", Granada

Sponsors
All Listed Sponsors
collaborator

Actial Farmaceutica S.r.l.

INDUSTRY

collaborator

Ferring Pharmaceuticals

INDUSTRY

lead

Elena Pita Calandre

OTHER